Pharmafile Logo

Souvenaid

- PMLiVE

Immuno-oncology at ASCO: survival data, combinations and new indications

The abstracts reveal heaps of strong contenders in the NSCLC category

- PMLiVE

Pharma and biotech leaders back ’no deal’ Brexit warning

Ongoing division in Conservative party means 'no deal' remains a possibility

- PMLiVE

AstraZeneca and Emulate advance ‘organs-on-chips’ research partnership

Company advances partnership, aiming to integrate technology into full-scale R&D efforts

Lucid’s magic touch is recognised as they make the shortlist in five different categories for Communiqué 2018

Lucid has been working its magic with its clients again!Four of their pioneering programmes have been shortlisted as finalists for this year’s Communiqué awards. And they have been shortlisted for...

Lucid Group Communications Limited

- PMLiVE

Novo Nordisk expands cell therapy R&D, says type 1 diabetes cure a step closer

Company has reached milestone in stem cell therapy as it looks to broaden range beyond diabetes

- PMLiVE

Novartis legal head resigns over Cohen payments

General counsel steps down, but Novartis still facing difficult questions

- PMLiVE

New appointments at 90TEN and WA Health

The latest movers and shakers from agencies and consultancies

Eli Lilly HQ

Lilly adds AurKa Pharma to oncology buying spree

Lilly is buying back its former drug after just two years

- PMLiVE

Breakthrough Device status for novel blood filtering immunotherapy

Novel technology aims to reactivate immune system in cancer patients

Personas: a top tool for personalising pharma marketing campaigns

Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively.

Blue Latitude Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links